The NAF1 and Beta-2 Microglobulin (B2M) expression data from CRC patients were determined from tumor and healthy intestinal tissue samples, and whether the patients were genotyped for the SNP rs17042479. The gene discussed is B2M; the disease is colorectal carcinoma.